Jeffrey P. Nadler

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 741 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of Pneumococcal Vaccine in High-Risk Patients

Michael S. Simberkoff, Anne Cross, Mohamed Al‐Ibrahim et al. · New England Journal of Medicine · 1986 · 401 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy

Calvin Cohen, Susan C. Hunt, Michael Sension et al. · AIDS · 2002 · 197 citations

Life Sciences, Pharmacotherapy, Hiv Control +16

Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy

Richard T. Davey, Robert L. Murphy, Andrew T. Pavia et al. · JAMA · 2000 · 176 citations

Life Sciences, Immunology, Infectious Diseases +15

The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy???Naive HIV-1-Infected Patients

A Rodriguez‐French, Jack Boghossian, Glenda Gray et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 150 citations

Medicine, Pharmacology, Pharmacotherapy +17